about
Loss of Ifnar1 in Pancreatic Acinar Cells Ameliorates the Disease Course of Acute PancreatitisImaging of pH in vivo using hyperpolarized 13C-labelled zymonic acidCRISPR/Cas9 somatic multiplex-mutagenesis for high-throughput functional cancer genomics in mice.Modeling Therapy Response and Spatial Tissue Distribution of Erlotinib in Pancreatic Cancer.A porcine model of osteosarcoma.Targeted positron emission tomography imaging of CXCR4 expression in patients with acute myeloid leukemiaAntifibrotic properties of transarterial oncolytic VSV therapy for hepatocellular carcinoma in rats with thioacetamide-induced liver fibrosis.Pathology, genetics and precursors of human and experimental pancreatic neoplasms: An update.Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR/Cas9 delivery in mice.Immuno-PET Imaging of Engineered Human T Cells in Tumors.Quantification of Endothelial αvβ3 Expression with High-Frequency Ultrasound and Targeted Microbubbles: In Vitro and In Vivo Studies.Variation of Specific Activities of 68Ga-Aquibeprin and 68Ga-Avebetrin Enables Selective PET Imaging of Different Expression Levels of Integrins α5β1 and αvβ3.Complementary, Selective PET Imaging of Integrin Subtypes α5β1 and αvβ3 Using 68Ga-Aquibeprin and 68Ga-Avebetrin.Model Matters: Differences in Orthotopic Rat Hepatocellular Carcinoma Physiology Determine Therapy Response to Sorafenib.DKK2 mediates osteolysis, invasiveness, and metastatic spread in Ewing sarcoma.PET imaging of oncolytic VSV expressing the mutant HSV-1 thymidine kinase transgene in a preclinical HCC rat model.A conditional piggyBac transposition system for genetic screening in mice identifies oncogenic networks in pancreatic cancer.Helicobacter pylori γ-glutamyl transferase contributes to colonization and differential recruitment of T cells during persistence.Morphology of canine placental sites after induced embryonic or fetal death.Apparent Diffusion Coefficient (ADC) predicts therapy response in pancreatic ductal adenocarcinoma.Appendiceal goblet cell carcinoids and adenocarcinomas ex-goblet cell carcinoid are genetically distinct from primary colorectal-type adenocarcinoma of the appendix.PD-L1 and PD-1 and characterization of tumor-infiltrating lymphocytes in high grade sarcomas of soft tissue - prognostic implications and rationale for immunotherapy.Administration of Gemcitabine After Pancreatic Tumor Resection in Mice Induces an Antitumor Immune Response Mediated by Natural Killer Cells.Probing lactate secretion in tumours with hyperpolarised NMR.NRG1 Fusions in KRAS Wild-type Pancreatic Cancer.Cytosolic nucleic acid sensors of the innate immune system promote liver regeneration after partial hepatectomyChronic Pancreatitis with Acinar–Ductal Metaplasia and Ductal Dysplasia in a HorsePiggyBac transposon tools for recessive screening identify B-cell lymphoma drivers in miceDetection of equine herpesvirus-1 in the fetal membranes of aborted equine fetuses by immunohistochemical and in-situ hybridization techniquesKnockdown of Virus Antigen Expression Increases Therapeutic Vaccine Efficacy in High-Titer Hepatitis B Virus Carrier MiceA critical role for Akt1 signaling in acute pancreatitis progression†Combined Inhibition of Epigenetic Readers and Transcription Initiation Targets the EWS-ETS Transcriptional Program in Ewing SarcomaRIG-I activation is critical for responsiveness to checkpoint blockadeImage-Based Molecular Phenotyping of Pancreatic Ductal AdenocarcinomaSeveral genotypes, one phenotype: PIK3CA/AKT1 mutation-negative hidradenoma papilliferum show genetic lesions in other components of the signalling networkA Novel Approach for Image-Guided 131I Therapy of Pancreatic Ductal Adenocarcinoma Using Mesenchymal Stem Cell-Mediated NIS Gene DeliveryGlycemic Variability Promotes Both Local Invasion and Metastatic Colonization by Pancreatic Ductal AdenocarcinomaSynergy of therapeutic heterologous prime-boost hepatitis B vaccination with CpG-application to improve immune control of persistent HBV infectionSystemic antitumor effect by regional hyperthermia combined with low-dose chemotherapy and immunologic correlates in an adolescent patient with rhabdomyosarcoma - a case reportRadiation-Induced Amplification of TGFB1-Induced Mesenchymal Stem Cell-Mediated Sodium Iodide Symporter (NIS) Gene 131I Therapy
P50
Q27339244-92EE60A6-DA5F-46F2-A19E-5C02EC7247D9Q33829737-8356E2F3-75FE-4093-AD31-36C336B560FAQ34499647-E36D665B-0AC3-4ED8-B01D-0D43F85954A5Q35908018-BF43EF65-3735-4DE5-822A-B0F8513B88BAQ36748704-0D4D8CDD-5B47-4C16-83B4-1204E4E8E6A1Q37140477-14512AFC-ACC0-4028-A08D-871CF2DC56DAQ37316860-D2A59395-3CCF-4768-AF9F-B05FCFBA3F53Q38585961-3AB39097-9AD4-4A71-8C9F-A55B61AFFBF3Q38707232-FBB30CFF-79A2-4ED7-994C-3D9DE873C2A9Q38761080-61DA1970-167F-44DF-AD38-BA3882C40E0EQ38764386-0092C6C9-3575-4FD5-98DF-F5FF0F91ECD4Q38772835-B6724849-F85C-48D6-A37D-D0232AD444C1Q38814445-2B102980-FDCD-41EC-80C7-5B4503C1344AQ39004241-857A9ABC-D484-4E5B-8097-07F278EF6F40Q39233911-8F0B64DA-AE57-487B-9F91-4D49DB6D1EA6Q39600108-2A525E2F-AEDA-484D-8C39-D9B002A5DD61Q41716703-22077BD1-AA41-4980-A17F-35587EF89042Q42653089-82AA2F47-21E9-4A1D-990B-18A7F5684B88Q46946709-C08A0960-41C3-454E-B313-5905F9585C09Q47098844-BF13B413-D648-4BBE-8A98-A56518DE7EA7Q48254792-CE45F6F7-E099-48F9-8643-9CDAF0DEC864Q52699886-E14F08A9-4F90-46F9-8A3F-6E239DF348D4Q52852031-E87BA9A0-86E3-4D97-9F75-32BC4AD4DF5FQ53077767-3EDBB283-8814-4BD5-8AA0-5EDC4EECE356Q54978186-5D6345BC-5B0C-4DC7-B536-EC784E1E36D2Q58774511-5288D3D4-3F9A-43AB-B2AF-D236D9AB2C5EQ62066192-D901B83C-FF81-4277-A3A5-0C4184232278Q64104353-3A8C1E44-9E5A-49C8-93A4-982058EEFE2AQ73816055-26DE55EA-38B2-48DC-B93D-C10239D0A052Q89452313-3808C159-83A7-4DA5-A93A-1EE98BAC1D83Q89463409-5B40FFBD-839A-457E-9AA4-A74C97143998Q89510239-81D2F64B-84FE-4FC3-8064-89371BD98114Q90100248-BAC56D1D-E530-4F4D-B9CE-C9273AADC384Q90191986-488089B3-BA00-4B68-83EC-57C4D9343DF0Q90210878-21D3A137-E8D6-4A0E-A424-36628EDB1330Q91493735-8ADC984A-4815-4F6A-8166-55125727F43EQ91792797-A81EDEB7-F8B2-4A55-96D5-C2CCFCE26FCFQ92186305-E05CA58C-B577-4490-AC39-8355F3E79546Q92522565-0D56EF33-F57F-48A2-B079-DDB8184E29B0Q92731520-BE824F53-500A-4EC2-A7DA-DF1528C26048
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Katja Steiger
@ast
Katja Steiger
@en
Katja Steiger
@es
Katja Steiger
@nl
Katja Steiger
@sl
type
label
Katja Steiger
@ast
Katja Steiger
@en
Katja Steiger
@es
Katja Steiger
@nl
Katja Steiger
@sl
prefLabel
Katja Steiger
@ast
Katja Steiger
@en
Katja Steiger
@es
Katja Steiger
@nl
Katja Steiger
@sl
P106
P31
P496
0000-0002-7269-5433